Found 52 matching trials
Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major
PHASE1A wide spectrum of immune abnormalities has been described by numerous stud...
Location
Department of Immunology, School of Medicine, Shiraz University of Medical Sciences
Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload
NAThalassemic patients often suffer from iron overload due to frequent blood ...
Location
Hormozgan University of Medical Sciences (HUMS)
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes
PHASE2The general aim of this study is to investigate the influence of systemic a...
Location
Karolinska University Hospital
Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment
PHASE2The purpose of this trial is to evaluate changes in cardiac iron as measure...
Location
Childrens Hospital of Los Angeles
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
N/APatients who have iron overload due to chronic blood transfusions and have ...
Status
Approved For Marketing
Location
The Children's Hospital of Philadelphia
Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
PHASE4Changes in chelation treatment and transfusion practices, during the past t...
Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment
PHASE1Approximately 60 subjects will be enrolled into this double-blind, placebo-...
Location
University of Alabama at Birmingham
iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine
PHASE2This is a single center open-label feasibility trial involving a single stu...
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
PHASE2The investigators hypothesize that treatment with the iron chelator, Defero...
Location
St. Joseph's Hospital / Barrow Neurological Institute
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
PHASE1The researchers are doing this study to find out whether deferoxamine (DFO)...
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)